Skip to main content

Table 2 Cell death induced by rituximab and obinutuzumab in MCL

From: Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

 

Rituximab

Obinutuzumab

Rituximab vs obinutuzumab

Cell death (%)

p-value

Cell death (%)

p-value

p-value

JeKo-1

1.31. ± 0.26

0.024*

3.00 ± 1.02

0.012*

0.030*

REC-1

2.15 ± 0.85

0.029*

2.64 ± 1.31

0.038*

0.493

  1. * p < 0.05